Treatment for Pruritic Rash on the Foot

Initial Assessment and Management

The American College of Dermatology recommends evaluating the rash characteristics to determine potential causes, such as fungal infection, contact dermatitis, or eczema, and applying emollients regularly to maintain skin hydration and barrier function, with a strength of evidence level of moderate 1, 2
For mild localized pruritus, the American Academy of Dermatology suggests using moderate-potency topical corticosteroids to reduce inflammation and itching, with a strength of evidence level of high 1, 2
Consider topical menthol-containing preparations for additional itch relief, with a strength of evidence level of low 1, 2

Apply moderate-potency topical corticosteroids, such as mometasone furoate 0.1% or betamethasone valerate 0.1%, twice daily for 1-2 weeks, with a strength of evidence level of high 1, 2
For daytime use, non-sedating second-generation antihistamines, such as loratadine 10 mg daily, can be used, with a strength of evidence level of moderate 1, 2

For nighttime use, first-generation antihistamines with sedative properties, such as diphenhydramine 25-50 mg or hydroxyzine 25-50 mg, can be used, with a strength of evidence level of low 1, 2

Consider referral to dermatology for evaluation and possible skin biopsy, with a strength of evidence level of high 3, 4
For severe, persistent pruritus, consider gabapentin (900-3600 mg daily) or pregabalin (25-150 mg daily), with a strength of evidence level of moderate 1, 2
Phototherapy may be beneficial for severe cases not responding to other treatments, with a strength of evidence level of low 1, 3

Identify and remove potential allergens or irritants, with a strength of evidence level of high 3, 2
Consider patch testing if recurrent episodes occur, with a strength of evidence level of moderate 2

Avoid long-term use of topical corticosteroids (>2-4 weeks) due to risk of skin atrophy and tachyphylaxis, with a strength of evidence level of high 1
Sedative antihistamines should be used with caution, especially in elderly patients, due to risk of cognitive impairment, with a strength of evidence level of moderate 5, 2
If no improvement after 2 weeks of appropriate therapy, reassess diagnosis and consider dermatology referral, with a strength of evidence level of high 1, 3
For persistent or spreading rash despite treatment, consider underlying systemic conditions that may cause pruritus, with a strength of evidence level of low 6